Therefore, the NLRP3 inflammasome plays a critical role in the development and progression of DCM, which provides new insights into the molecular mechanisms of DCM as well as potential therapeutic targets for its prevention and treatment. The gene discussed is NLRP3; the disease is familial dilated cardiomyopathy.